INTERIM REPORT JANUARY 1 - SEPTEMBER 30, 2011

| Source: RaySearch Laboratories AB RaySearch Laboratories AB 

INTERIM REPORT JANUARY 1 - SEPTEMBER 30, 2011

JANUARY 1 - SEPTEMBER 30, 2011

  · Net sales for the period totaled SEK 80.3 M (83.0)
  · Profit after tax amounted to SEK 10.2 M (17.5) and earnings per
share totaled SEK 0.30 M (0.51)
  · Operating profit totaled SEK 13.0 M (24.5)
  · Cash flow was a negative SEK 30.8 M (neg: 2.8)
  · A total of seven orders for RayStation® were received from
Switzerland, Canada, the Netherlands and the US
  · A sales organization was established in the US in January
  · RaySearch licensed pioneering technology from Princess Margaret
Hospital in March
  · RaySearch became involved in a US patent dispute in May
  · Distribution agreements were signed for the Italian market in
September
  · The first patient was treated with RayStation® in September

AFTER THE END OF THE PERIOD

  · Two US hospitals placed orders for RayStation® in October
  · RaySearch entered South Korean distribution agreement in November

 
“Financially, we had a strong third quarter so we recovered after a weak
first half of the year. The end of the year promises to be highly
interesting,” says Johan Löf, President of RaySearch.

“In 2011, we have focused on our strategic shift from complete
dependence on partners to establishing opportunities to sell directly to
clinics in parallel with our partner-based business model. Our order
book has now started to grow as a result of the considerable interest
shown in RayStation®, particularly in the US, and we have high hopes of
completing a few more transactions toward the end of 2011,” concludes
Johan Löf.

ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch's products are mainly sold through license agreements with
leading partners such as Philips, Nucletron, IBA Dosimetry, Varian,
Accuray and Siemens. To date, 15 products have been launched through
partners and RaySearch's software is used at some 1,800 clinics in more
than 30 countries. In addition, RaySearch offers the proprietary
treatment planning system RayStation® directly to clinics. RaySearch was
founded in 2000 as a spin-off from Karolinska Institutet in Stockholm
and the company is listed in the Small Cap segment on NASDAQ OMX
Stockholm.

 
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
Johan Löf, President
Tel: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com
For more information about RaySearch, visit
www.raysearchlabs.com (http://www.raysearchlabs.com/).

Attachments